Changes in metabolic parameters and cardiovascular risk factors after therapeutic control of acromegaly vary with the treatment modality. Data from the Bicêtre cohort, and review of the literature - Briet, C; Ilie, M D; Kuhn, E (Endocrine, 2019)
et al.